Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management - Wikidata - awgldk - TriplyDB

Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management

Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management

http://www.wikidata.org/entity/Q28250136

about

Alterations in parenteral nutrition management for the treatment of parenteral nutrition-associated cholestasis in term and preterm infants Omega-3 Fatty Acids in Modern Parenteral Nutrition: A Review of the Current Evidence Parenteral fish oil-containing lipid emulsions may reverse parenteral nutrition-associated cholestasis in neonates: a systematic review and meta-analysis The role of inflammation in cholestasis: clinical and basic aspects Fish oil-based lipid emulsion: current updates on a promising novel therapy for the management of parenteral nutrition-associated liver disease Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease Clinical application of magnetic resonance spectroscopy of the liver in patients receiving long-term parenteral nutrition.The use of Omegaven in treating parenteral nutrition-associated liver disease.Decreased postnatal docosahexaenoic and arachidonic acid blood levels in premature infants are associated with neonatal morbidities.Specific microbiome changes in a mouse model of parenteral nutrition associated liver injury and intestinal inflammation.Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges.Improved survival in a multidisciplinary short bowel syndrome program.The relationship between the parenteral dose of fish oil supplementation and the variation of liver function tests in hospitalized adult patients Vitamin E in New-Generation Lipid Emulsions Protects Against Parenteral Nutrition-Associated Liver Disease in Parenteral Nutrition-Fed Preterm Pigs Kinetics of phytosterol metabolism in neonates receiving parenteral nutrition The essentiality of arachidonic acid and docosahexaenoic acid.Relationship between biopsy-proven parenteralnutrition-associated liver fibrosis and biochemical cholestasis in children with short bowel syndrome.Parenteral fish oil-associated burr cell anemia.Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients.Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury.Intravenous Lipid Emulsions in Parenteral Nutrition A comparison of 2 intravenous lipid emulsions: interim analysis of a randomized controlled trial.The use of fish oil lipid emulsion in the treatment of intestinal failure associated liver disease (IFALD).Lipid injectable emulsions: 2006.Short-term intravenous fish oil and pediatric intestinal failure associated liver disease: 3-year follow-up on liver function and nutrition.Enhancing parenteral nutrition therapy for the neonate.Maternal dietary DHA supplementation to improve inflammatory outcomes in the preterm infant.Parenteral nutrition related hepato-biliary disease in adults.Pediatric intestinal failure: nutrition, pharmacologic, and surgical approaches.Treatment of parenteral nutrition-associated liver disease: the role of lipid emulsions.Fish oil-based lipid emulsions in the treatment of parenteral nutrition-associated liver disease: an ongoing positive experience.Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience.Use of Fish Oil-Based Lipid Emulsions in Infants With Intestinal Failure-Associated Liver Disease: A Case Series.Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome.Short bowel syndrome in children: current and potential therapies.Omega-3 long chain polyunsaturated Fatty acids for treatment of parenteral nutrition-associated liver disease: a review of the literature Intestinal rehabilitation and transplantation for intestinal failure.Medical update and potential advances in the treatment of pediatric intestinal failure.Review and clinical update on parenteral nutrition-associated liver disease.Nutrition management of infants with surgical short bowel syndrome and intestinal failure.

P2860

Q24240633-DF361B89-3A71-48FA-A806-10DE3AFE9480 Q26766717-18B298FB-BF1F-4FB7-996E-46A394DCFEF5 Q27013967-475846D6-98B7-4662-BB29-7D5222B16B7F Q27694662-44DAAAAD-0994-4417-93BA-12C64131E187 Q28085111-4B055F4F-0015-4FB8-B3F0-175AA13BDF32 Q28291979-CC532600-E721-4FBB-8431-977C287E7BDB Q33479921-53E50AF3-BE87-4A4A-BAB8-2D4E279372A4 Q34174212-DEADAD9C-C858-40C9-AF21-6C370DA41B45 Q34191272-3308CFFA-A60B-4C46-8D33-ADFAFF5FF9F4 Q34374168-700B20E8-AFE9-4EA4-80CA-6931C98B9F6B Q34726758-97CC7690-8E3F-4195-810B-BB0BEFDE0EDE Q35659591-75473999-D9BA-4ED3-B740-1C1167C1D3DF Q35809593-30404044-7CA1-405F-B0A1-340997A7FEB3 Q35858834-E10010FB-547E-4143-A86B-00F914DE2F15 Q35988336-F71C73AF-7047-4571-9042-5268F7AF2DAE Q35992699-AF467AE5-1541-4091-8227-764ACB65CED9 Q35992958-4F691937-E02A-4927-88D6-FE16FCD9C97E Q36002180-86C756A9-783D-467C-B124-16F53CB189F5 Q36002314-7C54EF62-AFEF-4EE0-A7DB-006A49897003 Q36004900-089D4BFE-A913-40FA-9B1F-F422D2799C83 Q36033721-9D0C59A6-1F94-4618-8D16-F82740BE3A7A Q36254936-41800CCC-A4F7-4D4E-B22F-7F67E7537F46 Q36538113-66FA7805-1536-4491-9C54-38AB50D75AEB Q36548143-1B48A2CA-6115-4D1C-B178-AB7E7DF6690A Q36557747-7446DEC0-6B16-4D96-80F4-97FC7B04CB22 Q36765310-2ECA3437-7B77-44F9-B49F-34D16B609A46 Q36830424-37AD321D-4308-46CC-B667-BBB6FFDBD149 Q36875966-C1E04DE4-692F-45A0-9FBE-557F923A13DC Q37016607-970777E4-F02E-4967-9414-9B3413C73415 Q37296480-F56F0953-0EF7-46A0-93E3-905B472C5FD1 Q37446645-13AE2BB9-7586-427A-9D0D-C98034914D99 Q37538088-C7E975F2-F686-4687-ABBD-5FB927D3842A Q37576936-6F374B5F-8906-4927-A976-1F40A2702923 Q37736147-441B5121-3935-4AB3-9752-F89AB3EE2EA4 Q37997502-F92C81C2-33E7-46F6-B6F3-5835D97301D6 Q38000190-454FA2B6-880B-46ED-96E2-BF593A40292C Q38002372-D490940A-402B-444D-84A3-4BA546974D80 Q38005027-66516395-4E4F-40F6-839E-B0026D1D591D Q38054057-2E849AB0-81AC-4D62-B305-20944CFBEAA6 Q38114043-A69FDEDF-8A9C-48AB-95D0-41FF9ECDE4D8

P2860

Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management

http://www.wikidata.org/entity/Q28250136

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Reversal of parenteral nutriti ...... ications for future management

@ast

Reversal of parenteral nutriti ...... ications for future management

@en

Reversal of parenteral nutriti ...... ications for future management

@nl

type

label

Reversal of parenteral nutriti ...... ications for future management

@ast

Reversal of parenteral nutriti ...... ications for future management

@en

Reversal of parenteral nutriti ...... ications for future management

@nl

prefLabel

Reversal of parenteral nutriti ...... ications for future management

@ast

Reversal of parenteral nutriti ...... ications for future management

@en

Reversal of parenteral nutriti ...... ications for future management

@nl

P1433

Q28250136-E3CA8792-4976-4434-9289-298F3DB9E837

P1476

Q28250136-2E94E6E2-5E2C-467C-B106-5AD0B5D8C391

P2093

Q28250136-1EB7F152-793E-4F96-983A-E82B80E7A0E3

Q28250136-31BF6D15-EDF3-4BE9-A655-E4F6CC27CA1A

Q28250136-5685C5B1-D57B-488D-87B0-50EE4CF1D607

Q28250136-5FBC7263-4030-40FC-9B86-17BF5F443088

Q28250136-640382D8-05DD-4B70-9B05-C96229100C87

Q28250136-7710FDF3-2A82-48F1-A19D-7AB088AF0714

Q28250136-F332FD1F-24FB-436A-8E77-AF55B531C10E

P304

Q28250136-4B2044C3-66ED-46A5-A69B-B5C40B46CC4F

P31

Q28250136-8F8D1056-B8ED-4223-9A47-20AD9578C074

P356

Q28250136-9F96212E-7654-4A0C-87AA-C04EF86539CA

P407

Q28250136-144E71B1-7C5A-46AD-869A-7D5524216AF4

P433

Q28250136-8F996F4A-609A-40FA-B76E-DBC747B910DC

P478

Q28250136-173D8828-EDC0-4271-8DF4-6719D46FDCA9

P577

Q28250136-7719C5BB-246D-484F-B903-DD7C9D298363

P5875

Q28250136-7750C055-4271-4CE3-9E82-306AEFCE3210

P698

Q28250136-EF3793F7-B844-4E6E-9813-67C8EAC071CC

P356

P1433

P1476

Reversal of parenteral nutriti ...... ications for future management

@en

P2093

Bruce R Bistrian

http://www.w3.org/2001/XMLSchema#string

Christopher P Duggan

http://www.w3.org/2001/XMLSchema#string

Judah Folkman

http://www.w3.org/2001/XMLSchema#string

Kathleen M Gura

http://www.w3.org/2001/XMLSchema#string

Mark Puder

http://www.w3.org/2001/XMLSchema#string

Russell W Jennings

http://www.w3.org/2001/XMLSchema#string

Sharon B Collier

http://www.w3.org/2001/XMLSchema#string

P304

e197-201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1542/PEDS.2005-2662

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6965498

http://www.w3.org/2001/XMLSchema#string

P698

16818533

http://www.w3.org/2001/XMLSchema#string